NVS as reported
- Op Margin
- 35%
Op Margin · trailing twelve months to Q2 2025
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Gross Margin | 80% | n/a | Q2 2025 |
| Op Margin | 35% | n/a | Q2 2025 |
| Net Margin | 28% | n/a | Q2 2025 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Novartis AG (NVS) - Revenue & ProfitRevenue & ProfitNovartis AG (NVS)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Drug Manufacturers - General
Ranks #10 of 16 by Smart Score